metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Effect of methyl donor supplementation on gut microbiota and hepatic expression ...
Journal Information
Vol. 29. Issue S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(February 2024)
Share
Share
Download PDF
More article options
Vol. 29. Issue S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(February 2024)
Full text access
Effect of methyl donor supplementation on gut microbiota and hepatic expression of key miRNAs in a murine model of MAFLD
Visits
181
Rebeca Rosas-Campos1, Ángel O. Vázquez-Esqueda1, Marina Galicia-Moreno1, Juan Armendáriz-Borunda1,2, Ana S. Sandoval-Rodríguez1
1 Institute of Molecular Biology in Medicine, Health Sciences Center, University of Guadalajara, Guadalajara, Mexico
2 School of Medicine and Health Sciences, Tecnologico de Monterrey, Guadalajara, Mexico
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Special issue
This article is part of special issue:
Vol. 29. Issue S2

Abstracts Asociación Mexicana del Hígado (AMH) 2023

More info
Introduction and Objectives

Metabolism-associated fatty liver disease (MAFLD) is the most common liver disease worldwide, and intestinal dysbiosis is associated with its development. Methyl donor supplementation has shown beneficial effects for MAFLD treatment; however, its role on the intestinal microbiota and miRNAs hepatic expression has been poorly studied. The aim of this study was to evaluate the effect of methyl group donor supplementation on gut microbiota and hepatic expression of key miRNAs in a murine model of MAFLD.

Materials and Patients

Twenty-four male C57BL/6J mice were divided into three groups: 1) Control: Conventional diet. 2) HF/FS: Diet rich in fats and sugars for 18 weeks. 3) HFMS: HF/FS diet for the first 10 weeks, followed by a HF/FS diet plus orogastric supplementation with methyl group donors for the last 8 weeks.

Results

The intestinal microbiota was characterized by 16S rRNA gene sequencing; supplementation with methyl donors modified microbial composition analyzed by beta diversity. In addition, HFMS group strongly tended to increase alpha diversity and induced enrichment of six genus: Acinetobacter, Anaeroplasma, Pseudomonas, Stenotrophomonas, Tuzzerella, and Moraxellaceae family. HFMS group significantly increased SCFAs fecal concentration and restored intestinal permeability dysfunction by increasing Ocln and Cldn1 expression; consequently, a decrease in liver inflammation was observed due to a decrease in Tnf-a expression. On the other hand, HFMS group significantly increased hepatic expression of miR-122 and decreased miR-33a expression.

Conclusions

This study offers valuable insights into the role of methyl donors as microbiota modifiers, highlighting their ability to promote restoration of intestinal health and liver metabolism. These findings contribute to the proposition that methyl donors could be a promising strategy for treating MAFLD and hepatic related conditions.

Full Text

Ethical statement

The protocol was registered and approved by the Ethics Committee.

Declaration of interests

None

Funding

None

Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos